XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) per Share
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Net Income (Loss) per Share Net Income (Loss) per Share
Basic net income or loss per share is determined by dividing net loss by the weighted average shares of common stock outstanding during the period, without consideration of potentially dilutive securities, except for those shares that are issuable for little or no cash consideration. Diluted net income or loss per share is determined by dividing net income or loss by diluted weighted average shares outstanding. Diluted weighted average shares reflects the dilutive effect, if any, of potentially dilutive common shares, such as stock options and warrants calculated using the treasury stock method. In periods with reported net operating losses, all common stock options, convertible preferred shares, and preferred and common warrants are generally deemed anti-dilutive such that basic net loss per share and diluted net loss per share are equal.
As of September 30, 2025 and 2024, the Company had 1,341,375 and 737,421 pre-funded warrants outstanding, respectively. The following table provides a reconciliation of the weighted average shares outstanding calculation for the three and nine months ended September 30, 2025 and 2024:
Weighted average number of basic shares outstanding
Three months ended September 30,Nine months ended September 30,
2025202420252024
Weighted average shares issued35,041,90228,000,88634,269,24426,347,229
Weighted average pre-funded warrants1,341,375737,4211,341,375987,983
Weighted average shares outstanding36,383,27728,738,30735,610,61927,335,212
Weighted average number of diluted shares outstanding
Three months ended September 30,Nine months ended September 30,
2025202420252024
Weighted average shares outstanding (Basic)36,383,27728,738,30735,610,61927,335,212
Additional dilutive shares3,673,5373,607,365 4,339,322 — 
Weighted average shares outstanding (Diluted)40,056,81432,345,67239,949,94127,335,212

The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2025 and 2024 because their effects would be anti-dilutive:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Common stock warrants3,610,743 3,627,409
Assumed conversion of preferred stock warrants— 4,108,328
Assumed conversion of preferred stock— 1,454,509
Assumed conversion of convertible notes237,614 237,614
Stock options3,510,5651,489,310 3,510,5656,055,728
Assumed conversion of ESPP42,57035,51242,57035,512
Total3,553,1355,373,1793,553,13515,519,100